Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absorb, Affordability, Affordable, apportionment, attrition, benchmark, beneficiary, Berkeley, biomarker, BRCA, bundling, Cancerpublished, capita, capture, CHF, context, contrary, convened, coordination, copyright, Dean, Editorial, Electric, faster, filled, gave, GE, Homeownership, impotence, indirect, inLancet, instructed, investee, involuntarily, IPAB, Ireland, led, lost, Mexico, mix, movement, NGS, nominal, numerator, oncologist, PPACA, prolonged, prompted, prostatectomy, Quick, radical, relief, ribonucleic, role, satisfaction, Schorno, seasonal, shortage, Simple, spokesperson, theBritish, travel, Treatmentpublished, uncollectible, unpatentable, vacation, VIE, warranted, Worker
Removed:
abroad, Agendia, attributed, auditing, back, borrowed, catalog, Clarient, closed, comparable, complied, deducting, defer, deliver, Genzyme, goal, hardware, insurer, legislated, lender, margin, MD, MMA, notify, occupied, owing, paragraph, partnering, peer, preceding, premium, prepay, prescribed, profitable, ranging, reflecting, registration, restricting, retroactively, SAR, secured, shelf, taxable, underwriting, underwritten, vested
Filing tables
Filing exhibits
Related press release
GHDX similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-128805) pertaining to the 2005 Stock Incentive Plan and 2001 Stock Incentive Plan of Genomic Health, Inc., the Registration Statement on Form S-8 (No. 333-163006) pertaining to the 2005 Stock Incentive Plan of Genomic Health, Inc., and the Registration Statement on Form S-3 (No. 333-167868) of Genomic Health, Inc. of our reports dated March 11, 2011, with respect to the consolidated financial statements and schedule of Genomic Health, Inc., and the effectiveness of internal control over financial reporting of Genomic Health, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2010.
/s/ Ernst & Young LLP
Palo Alto, California
March 11, 2011
March 11, 2011